Lung Cancer Panel-FSP Precision Medicine Panel #1

Video Transcription

Video Summary

The discussion focused on precision medicine and interdisciplinary collaboration in thoracic oncology at Moffitt and Baptist Health. Clinicians and pathologists emphasized the importance of disease-specific and molecular pathology, digital pathology, and clear communication to guide treatment. Oncologists described the challenge of keeping up with rapidly evolving therapies through lifelong study, conferences, podcasts, and social media. They also discussed using AI tools to draft insurance appeal letters and advocate for patients when treatments are denied.<br /><br />A major theme was clinical trials: they are presented as additional treatment options, often especially valued by patients at Moffitt. The group also stressed conserving tissue for molecular testing, improving pathology reports with actionable details, and standardizing notes on specimen adequacy. Farah Khalil explained how Moffitt triages tissue and reflex testing, while James Saller described reporting variants with greater specificity. The session ended with an audience question about AI agents and hallucination, with OpenEvidence suggested for reliable medical literature.

Keywords

precision medicine

thoracic oncology

digital pathology

clinical trials

molecular testing

AI medical literature